| scholarly article | Q13442814 |
| P50 | author | Didier Raoult | Q915676 |
| P2093 | author name string | J.-M. Rolain | |
| A. Roch | |||
| L. Papazian | |||
| M. Castanier | |||
| P2860 | cites work | Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production | Q34309451 |
| Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii. | Q34764355 | ||
| Acinetobacter baumannii: emergence of a successful pathogen | Q34795807 | ||
| Insertion sequence ISAba11 is involved in colistin resistance and loss of lipopolysaccharide in Acinetobacter baumannii. | Q35005140 | ||
| Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system | Q37333088 | ||
| Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital | Q43756833 | ||
| New insights into the antibacterial mechanism of action of squalamine. | Q52601400 | ||
| In vitro antibacterial activity of aminosterols against multidrug-resistant bacteria from patients with cystic fibrosis | Q56588130 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | case report | Q2782326 |
| Acinetobacter baumannii | Q3241189 | ||
| P304 | page(s) | 1146-1147 | |
| P577 | publication date | 2011-08-31 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Acinetobacter baumannii Resistant to Colistin With Impaired Virulence: A Case Report From France | |
| P478 | volume | 204 |
| Q21131083 | A new strategy to fight antimicrobial resistance: the revival of old antibiotics |
| Q39649887 | Activity of Gallium Meso- and Protoporphyrin IX against Biofilms of Multidrug-Resistant Acinetobacter baumannii Isolates |
| Q36757725 | Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world? |
| Q37544333 | Biological cost of different mechanisms of colistin resistance and their impact on virulence in Acinetobacter baumannii. |
| Q34321442 | Carbapenem resistance and Acinetobacter baumannii in Senegal: the paradigm of a common phenomenon in natural reservoirs |
| Q53703223 | Chromosomally encoded and plasmid-mediated polymyxins resistance in Acinetobacter baumannii: a huge public health threat. |
| Q64124128 | Colistin Heteroresistance and Involvement of the PmrAB Regulatory System in Acinetobacter baumannii |
| Q37124050 | Colistin resistance in a clinical Acinetobacter baumannii strain appearing after colistin treatment: effect on virulence and bacterial fitness. |
| Q37996299 | Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies |
| Q36644871 | Colistin-Resistant Acinetobacter baumannii Clinical Strains with Deficient Biofilm Formation |
| Q38048852 | Colistin: an update on the antibiotic of the 21st century |
| Q34632985 | Comparative analysis of surface-exposed virulence factors of Acinetobacter baumannii |
| Q40996390 | Gene expression analysis in human polymorphonuclear leukocytes stimulated by LPSs from nosocomial opportunistic pathogens |
| Q39063044 | Genetic Regulation of Virulence and Antibiotic Resistance in Acinetobacter baumannii |
| Q36973626 | Genomic insights into the fate of colistin resistance and Acinetobacter baumannii during patient treatment |
| Q37544704 | Growth retardation, reduced invasiveness, and impaired colistin-mediated cell death associated with colistin resistance development in Acinetobacter baumannii |
| Q36573679 | Immunoprotective Efficacy of Acinetobacter baumannii Outer Membrane Protein, FilF, Predicted In silico as a Potential Vaccine Candidate |
| Q42367786 | Immunoprotective potential of BamA, the outer membrane protein assembly factor, against MDR Acinetobacter baumannii |
| Q42930254 | Impaired virulence and fitness of a colistin-resistant clinical isolate of Acinetobacter baumannii in a rat model of pneumonia |
| Q40246727 | In vitro evaluation of the susceptibility of Acinetobacter baumannii isolates to antiseptics and disinfectants: comparison between clinical and environmental isolates |
| Q47136007 | Interplay between Colistin Resistance, Virulence and Fitness in Acinetobacter baumannii |
| Q46919961 | Investigation of Acinetobacter baumannii resistance to carbapenems in Marseille hospitals, south of France: a transition from an epidemic to an endemic situation |
| Q38287949 | Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria |
| Q26824934 | Novel derivatives of polymyxins |
| Q36493352 | Post-neurosurgical meningitis caused by acinetobacter baumannii: case series and review of the literature |
| Q64120082 | Rapid Replacement of Acinetobacter baumannii Strains Accompanied by Changes in Lipooligosaccharide Loci and Resistance Gene Repertoire |
| Q34168334 | Rapid detection of carbapenem resistance in Acinetobacter baumannii using matrix-assisted laser desorption ionization-time of flight mass spectrometry |
| Q36505442 | Real-time sequencing to decipher the molecular mechanism of resistance of a clinical pan-drug-resistant Acinetobacter baumannii isolate from Marseille, France |
| Q41998459 | Retention of virulence following adaptation to colistin in Acinetobacter baumannii reflects the mechanism of resistance. |
| Q35905605 | The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace |
| Q38049332 | Therapeutic options for Acinetobacter baumannii infections: an update |
Search more.